Drug
HRS-2129 Placebo
HRS-2129 Placebo is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
completed250%
recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
recruitingphase_1
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
NCT07377721
recruitingphase_1
Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics
NCT06780267
completedphase_1
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
NCT06742840
completedphase_1
A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
NCT06619392
Clinical Trials (4)
Showing 4 of 4 trials
NCT07377721Phase 1
A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain
NCT06780267Phase 1
Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics
NCT06742840Phase 1
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
NCT06619392Phase 1
A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4